Psychedelics and Consciousness: Distinctions, Demarcations, and Opportunities

Yaden and colleagues frame the paper by noting renewed scientific interest in psychedelic substances and their striking effects on subjective experience. They observe that some commentators and popular books suggest psychedelics might illuminate the nature of consciousness, but they caution that the term "consciousness" is used in multiple, often conflated ways. The authors set out to clarify these different senses of consciousness and to evaluate what psychedelic research can and cannot reasonably contribute, distinguishing between the so-called "hard problem" (explaining phenomenal experience itself) and a variety of "easy problems" (mechanistic questions about perception, attention, selfhood and related contents of consciousness). The review aims to assess philosophical distinctions, neuroscientific models proposed to explain psychedelic effects, and empirical findings about subjective psychedelic states. Throughout, the investigators emphasise the need for epistemic humility: to separate modest, testable scientific claims about the contents and functions of consciousness from stronger claims about solving the hard problem of how subjective experience arises.

This paper is a conceptual and narrative review rather than a systematic review or meta-analysis; the extracted text does not provide a formal methods section describing literature search, inclusion criteria, or a reproducible search strategy. Instead, the authors synthesise philosophical distinctions and a selection of neuroscience models and empirical findings relevant to psychedelics and consciousness. The investigators organise the material around three domains: philosophical framing of the hard versus easy problems of consciousness; evaluation of prominent neuroscientific models of psychedelic action (notably REBUS/entropic brain, cortico‑striato‑thalamo‑cortical circuits, and claustro‑cortical hypotheses); and characterisation of subjective effects and altered states occasioned by psychedelics, including measures such as the Mystical Experience Questionnaire (MEQ30) and the five‑dimensional altered states of consciousness scale. Their approach emphasises conceptual analysis and critical appraisal of empirical evidence cited in the literature, noting limitations in sample sizes, heterogeneity of measures, and specificity of reported neural effects. The extracted text does not report formal risk-of-bias assessment, meta-analytic modelling, or a quantitative synthesis of studies.

On philosophical framing, the authors review the distinction between the hard problem—explaining phenomenal consciousness or "what it feels like"—and the easy problems, which concern mechanistic explanations of perception, attention, reportability and related processes. They argue that phenomenal consciousness is privately accessible and that its verifiability limits what observational science can claim about the hard problem. By contrast, the contents of consciousness and many associated processes are tractable targets for scientific investigation. Regarding neuroscientific models, the review considers three influential proposals. First, the REBUS/entropic brain framework posits that psychedelics increase brain entropy and relax top-down priors, especially in default mode network hierarchies, allowing bottom-up information greater influence on perception and cognition. Empirical support cited includes observations of increased measures of neural entropy during acute psychedelic effects, but the authors highlight that the underlying studies are small, that entropy has been operationalised in many different ways, and that similar imaging changes have been reported after drugs other than classic psychedelics. They also note mixed evidence regarding predicted increases in prediction errors and questions about the specificity of claims regarding the DMN. REBUS generates testable hypotheses (for example, about disorders of consciousness), but the review finds little reason to believe it resolves the hard problem. Second, the cortico‑striato‑thalamo‑cortical (CSTC) model emphasises reduced thalamic sensory gating under 5‑HT2A agonism, producing increased thalamocortical information flow that might account for perceptual and cognitive alterations under psychedelics. Neuroimaging evidence includes increases in thalamic connectivity with cortex under LSD that correlate with subjective effects, and animal data on disrupted pre‑attentive gating. Metabolic findings are reported as mixed. The authors present CSTC as a productive circuit-level model for investigating easy problems such as perception and attention, but not as an explanation of phenomenal consciousness. Third, the claustro‑cortical circuit model focuses on the claustrum's widespread cortical connections and its proposed role in multisensory integration or binding; early philosophical proposals likened it to a conductor coordinating cortical activity. More recent human and animal data challenge a simple binding role for the claustrum, but psilocybin‑related changes in claustrum connectivity with default mode and frontoparietal networks have been observed. The review characterises the claustrum model as another way to generate testable hypotheses about cognitive network instantiation under psychedelics, again bearing on easy problems rather than the hard problem. On subjective effects, the authors describe how psychedelics reliably induce substantial altered states of consciousness that include perceptual changes, synesthesia, complex imagery, heightened feelings of connection, and alterations in self‑experience such as ego dissolution. They note standard instruments used to quantify these effects (e.g. MEQ30, five‑dimensional ASC) and outline the MEQ30 factors (unity/noetic quality, positive affect, altered time/space, ineffability). The review reports that mystical‑type and ego‑dissolution experiences induced by psychedelics are associated in some studies with lasting benefits in clinical and healthy samples. The investigators observe that the nomological network of psychedelic states is poorly specified: effects vary by substance, dose, set and setting, formulation and other biopsychosocial factors. They argue that psychedelics are currently among the most reliable tools to elicit particular altered states in controlled settings, which makes them valuable for studying aspects of conscious content. Finally, the review notes that psychedelic experiences can influence beliefs about the nature of consciousness (for example, shifts away from materialist views have been reported in some samples), but the evidence is mixed and population prevalence and magnitude of such belief changes are not well established.

The authors interpret their synthesis as supporting two central conclusions. First, psychedelic research is well placed to advance understanding of many of the easy problems of consciousness—mechanistic questions about perception, attention, self‑representation and the neural circuits that instantiate these processes. Models such as REBUS, CSTC and claustro‑cortical circuits generate testable hypotheses and have stimulated fruitful empirical work on brain dynamics, connectivity and subjective report. Second, the investigators emphasise that there is no clear scientific traction at present for using psychedelics to solve the hard problem of phenomenal consciousness. They argue that philosophical and methodological barriers—most notably the private, non‑observable character of phenomenal experience and the problem of other minds—mean that empirical psychedelic research is unlikely to bridge the explanatory gap. The authors stress that neuroscientific measures of complexity or entropy, even when altered under psychedelics, do not by themselves explain how qualia arise. Key limitations highlighted include small sample sizes underlying some reported neuroimaging findings, heterogeneity in how constructs such as entropy are operationalised, non‑specificity of some neural changes to classic psychedelics, and the absence of interventional data in certain proposed clinical applications (for example, no published studies administering psychedelics to patients with disorders of consciousness). The review also notes that subjective insights or noetic feelings under psychedelics can be compelling yet fallible, and that belief changes following psychedelic experiences are incompletely characterised across populations. In terms of implications, the authors call for careful use of terminology—distinguishing claims about phenomenal consciousness from claims about the contents and functions of consciousness—and for epistemic humility in both scientific and public discourse. They encourage continued empirical work using psychedelics as tools to probe specific, tractable questions about perception, selfhood and brain function, while cautioning against overstating implications for the metaphysical question of how subjective experience arises.